[go: up one dir, main page]

Gaffney et al., 1985 - Google Patents

Monoclonal antibodies against fibrinogen, fibrin and their fragments

Gaffney et al., 1985

Document ID
3899777558184396872
Author
Gaffney P
Jespersen J
Müller-Berghaus G
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

Since 1975, a procedure has been available to generate monoclonal antibodies (mabs) which bind to a precisely defined sequence of amino acids or detect a defined conformation of a sequence of amino acids. This method has been applied in studying coagulation factors …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/573—Immunoassay; Biospecific binding assay for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Elms et al. Measurement of crosslinked fibrin degradation products–an immunoassay using monoclonal antibodies
Holvoet et al. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA
Amiral et al. Application of enzyme immunoassays to coagulation testing.
US5206140A (en) Assay for soluble crosslinked fibrin polymers
Ota et al. Elevated levels of prothrombin fragment 1+ 2 indicate high risk of thrombosis
Falanga et al. Guidelines for clotting studies in cancer patients
Amiral et al. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A
US4609629A (en) Process for the immunological determination of proteins in body fluid which display a non-parallel inhibition curve to a reference inhibitor
Dempfle et al. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer
JPS61117457A (en) Monochronal antibody
Gaffney et al. Unreliability of current serum fibrin degradation product (FDP) assays
EP1190260B1 (en) Detection of von-willebrand factor (vwf) activity
Vecchi et al. Risk of thromboembolic complications in patients with inflammatory bowel disease: Study of hemostasis measurements
US6673561B1 (en) Diagnostic test for thrombotic or thromboembolic disease
JP2918688B2 (en) Immunoassay for prothrombin activating peptide and its degradation products and monoclonal antibody thereto
Gogstad et al. Assay of D-dimer based on immunofiltration and staining with gold colloids
McDuffie et al. Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation
JP3053503B2 (en) Testing methods for bone vulnerabilities and the risk of osteoporotic fractures
JP2657417B2 (en) Assay of soluble cross-linked fibrin polymer
Nilsson et al. A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3
Gaffney et al. Monoclonal antibodies against fibrinogen, fibrin and their fragments
AU674149B2 (en) Method for the determination of lupus anticoagulant antibodies that cause thrombosis
US5587291A (en) Method for the determination of plasmin α2 -antiplasmin complexes and the use of this method as a mean of determining changes in the fibrinolytic system
Falanga et al. Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia
US5840499A (en) Method and kit for detection of thrombin receptor activation of platelets and other cells